<DOC>
	<DOCNO>NCT02610218</DOCNO>
	<brief_summary>To evaluate clinical significance cell free DNA ( cfDNA ) circulate tumor cell ( CTCs ) real-time monitor therapeutic response HER2-targeted therapy histologically confirm HER2 positive advanced/metastatic gastric cancer .</brief_summary>
	<brief_title>Liquid Biopsy Monitoring Therapeutic Efficacy Targeted Therapy Advanced/Metastatic Gastric Cancer</brief_title>
	<detailed_description>The study single-center , prospective study undertaken anticipate 100 patient histologically confirm HER2 positive advanced/metastatic gastric cancer . Peripheral blood sample 12.5 mL collect patient cfDNA CTCs analysis . The blood sample respectively draw therapy , time patient achieve optimal response suffer progressive disease . The enumeration CTCs well detection HER2 expression achieve via integrated subtraction enrichment ( SET ) immunostaining-fluorescence situ hybridization ( iFISH ) platform . Further , geneomic analysis , enrich single CTC isolate single-cell targeted sequencing . While cfDNA analysis , extract DNA plasma directly subject target sequencing . The correlation HER2 status CTCs HER2 amplification cfDNA therapeutic response evaluate . Moreover , gene variation associate resistance HER2-targeted therapy also study base genomic data sequence CTC cfDNA .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Having sign informed consent Age≥ 18 year old Histologically confirm HER2 positive gastric adenocarcinoma Unresectable recurrent metastatic disease Measurable disease accord RECIST criterion Karnofsky performance status ≥60 Life expectancy ≥2 month ALT AST &lt; 2.5 time ULN ( ≤5 time ULN patient liver metastasis ) Serum albumin level ≥3.0g/dL Serum AKP &lt; 2.5 time ULN Serum creatinine &lt; ULN , CCr &lt; 60ml/min Bilirubin level &lt; 1.5 ULN WBC &gt; 3,000/mm3 , absolute neutrophil count ≥2000/mm3 , platelet &gt; 100,000/mm3 , Hb &gt; 9g/dl Brain metastasis ( know suspect ) Surgery ( exclude diagnostic biopsy ) within 4 week prior study entry . Contraindications nuclear magnetic resonance image fitment cardiac pacemaker , nerve stimulator , aneurysm clip , metallic foreign body eye ball . Allergic constitution allergic history protium biologic product investigate agent . Severe heart disease history record congestive heart failure , uncontrolled cardiac arrhythmia , angina pectoris need medication , cardiac valve disease , severe abnormal ECG finding , cardiac infarction , retractable hypertension . Pregnancy lactation period Other previous malignancy within 5 year , except nonmelanoma skin cancer Preexisting neuropathy &gt; grade 1 Legal incapacity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Cell free DNA</keyword>
	<keyword>Circulating tumor cell</keyword>
	<keyword>Therapeutic efficacy</keyword>
</DOC>